Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03244267 · ClinicalTrials.gov registry record · NA
App Reminder on ASA Adherence
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 195
- Enrollment target
NCT03244267 is a NA study that has completed, run by Emory University. The registered enrollment target is 195 participants.
The verdict
NCT03244267, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 195 participants
- Enrollment target
Study Summary
The purpose of this study is to explore the impact of using a smartphone app reminder on medication adherence twice daily in adults prescribed 81 milligrams of aspirin for 35 days as anti-thrombotic therapy after knee or hip arthroplasty. This study will randomly assign participants to get usual postoperative care which is teaching with verbal instructions and printed information about taking the aspirin at the time of discharge, or to have an app on your smartphone with preset reminders in addition to usual postoperative discharge teaching after surgery.
Interventions
- BEHAVIORAL Standard Education
- BEHAVIORAL Medication Reminder App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2017-10-03 |
| Est. Completion | 2019-03-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03244267
The ClinicalTrials.gov registry entry for NCT03244267 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Education is the first listed.
NCT03244267 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03244267 about?
NCT03244267 is a clinical study titled "App Reminder on ASA Adherence". The purpose of this study is to explore the impact of using a smartphone app reminder on medication adherence twice daily in adults prescribed 81 milligrams of aspirin for 35 days as anti-thrombotic therapy after knee or hip arthroplasty. This study will randomly assign participants to get usual po...
What is the current status of trial NCT03244267?
This trial is currently completed. It is a NA study. The enrollment target is 195 participants. The study started on 2017-10-03. Estimated completion is 2019-03-08.
What interventions are being tested in trial NCT03244267?
The interventions under investigation include: Standard Education (BEHAVIORAL), Medication Reminder App (BEHAVIORAL).
Who is sponsoring clinical trial NCT03244267?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.